Ikena Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/06/2025 | 5.02 M | $8.23 M | 0.00% | 10.40% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 4.09 M | $6.71 M | 0.00% | 8.48% |
| BVF INC/IL | 02/14/2025 | 4.01 M | $6.57 M | -15.99% | 8.30% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 3.59 M | $5.88 M | 395.77% | 7.43% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 3.54 M | $5.80 M | 0.00% | 7.33% |
| OMEGA FUND MANAGEMENT, LLC | 02/14/2025 | 2.25 M | $3.69 M | 0.00% | 4.66% |
| GILEAD SCIENCES, INC. | 02/13/2025 | 2.01 M | $3.29 M | 100.00% | 4.16% |
| VANGUARD GROUP INC | 02/11/2025 | 1.38 M | $2.27 M | 0.00% | 2.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 800,000 | $1.31 M | -19.02% | 1.66% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 600,063 | $984,103 | 0.00% | 1.24% |
| 01/29/2025 | 507,868 | $832,904 | 100.00% | 1.05% | |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 382,616 | $627,490 | 0.00% | 0.79% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 352,136 | $577,502 | -0.01% | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 330,200 | $541,528 | -17.57% | 0.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 327,962 | $537,978 | 21.01% | 0.68% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 288,368 | $471,000 | -11.47% | 0.60% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 199,684 | $327,482 | -19.94% | 0.41% |
| BARCLAYS PLC | 02/13/2025 | 195,311 | $320,000 | 0.00% | 0.40% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 157,400 | $258,136 | -22.12% | 0.33% |
| JPMORGAN CHASE & CO | 02/12/2025 | 155,741 | $255,415 | 18,244.05% | 0.32% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 153,800 | $252,232 | -2.90% | 0.32% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 100,778 | $165,276 | -35.69% | 0.21% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 02/06/2025 | 80,579 | $132,150 | 0.00% | 0.17% |
| MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 72,890 | $119,540 | 0.00% | 0.15% |
| JBF CAPITAL, INC. | 02/13/2025 | 72,647 | $119,141 | 0.00% | 0.15% |
| UBS GROUP AG | 02/14/2025 | 71,856 | $117,844 | 99,700.00% | 0.15% |
| BBR PARTNERS, LLC | 02/07/2025 | 70,000 | $114,800 | -46.15% | 0.15% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 47,095 | $77,236 | -19.66% | 0.10% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 44,040 | $72,226 | 100.00% | 0.09% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 43,640 | $71,570 | 100.00% | 0.09% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 38,621 | $63,225 | 0.00% | 0.08% |
| VAZIRANI ASSET MANAGEMENT LLC | 02/14/2025 | 25,000 | $41,000 | -78.39% | 0.05% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 21,184 | $34,741 | -4.34% | 0.04% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 02/07/2025 | 20,000 | $30,000 | 0.00% | 0.04% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 18,934 | $31,052 | 100.00% | 0.04% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 18,200 | $29,848 | -38.93% | 0.04% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 16,369 | $26,845 | -8.01% | 0.03% |
| XTX TOPCO LTD | 02/13/2025 | 12,528 | $20,546 | 100.00% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 12,304 | $20,179 | 1.97% | 0.03% |
| FMR LLC | 02/13/2025 | 10,587 | $17,363 | -72.41% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,633 | $5,958 | 93.76% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,503 | $2,600 | 0.00% | 0.00% |
| POINT72 (DIFC) LTD | 02/14/2025 | 564 | $926 | -91.60% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 235 | $386 | -21.40% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 108 | $177 | 0.00% | 0.00% |
| 02/06/2025 | 3 | $5 | 100.00% | 0.00% | |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ikena Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Ikena Oncology, Inc.. The most heavily invested institutionals were:
Atlas Venture Life Science Advisors, LLC: 5.02 M
Blue Owl Capital Holdings LP: 4.09 M
BVF INC/IL: 4.01 M
BML Capital Management, LLC: 3.59 M
ORBIMED ADVISORS LLC: 3.54 M
Omega Fund Management, LLC: 2.25 M
65.71% of Ikena Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.82 M shares in the last 24 months. This purchase volume represents approximately $56.14 M in transactions.